GB0220198D0 - Modified saccharides,conjugates thereof and their manufacture - Google Patents

Modified saccharides,conjugates thereof and their manufacture

Info

Publication number
GB0220198D0
GB0220198D0 GBGB0220198.6A GB0220198A GB0220198D0 GB 0220198 D0 GB0220198 D0 GB 0220198D0 GB 0220198 A GB0220198 A GB 0220198A GB 0220198 D0 GB0220198 D0 GB 0220198D0
Authority
GB
United Kingdom
Prior art keywords
conjugates
linker
new
manufacture
modified saccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0220198.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Priority to GBGB0220198.6A priority Critical patent/GB0220198D0/en
Publication of GB0220198D0 publication Critical patent/GB0220198D0/en
Priority to CN2010101825535A priority patent/CN101863998B/zh
Priority to AU2003260921A priority patent/AU2003260921B2/en
Priority to MXPA05002315A priority patent/MXPA05002315A/es
Priority to PCT/IB2003/004194 priority patent/WO2004019992A1/en
Priority to RU2005108992/04A priority patent/RU2005108992A/ru
Priority to DE60303961T priority patent/DE60303961T2/de
Priority to JP2004532625A priority patent/JP5268222B2/ja
Priority to ES03791149T priority patent/ES2260682T3/es
Priority to EP03791149A priority patent/EP1534342B1/en
Priority to DK03791149T priority patent/DK1534342T3/da
Priority to US10/526,124 priority patent/US8895516B2/en
Priority to AT03791149T priority patent/ATE319481T1/de
Priority to BR0314089-0A priority patent/BR0314089A/pt
Priority to CN038237245A priority patent/CN1688343B/zh
Priority to CA2497167A priority patent/CA2497167C/en
Priority to NZ538703A priority patent/NZ538703A/en
Priority to RU2008150551/13A priority patent/RU2531909C2/ru
Priority to JP2011228229A priority patent/JP5314745B2/ja
Priority to US14/521,761 priority patent/US20150166593A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0220198.6A 2002-08-30 2002-08-30 Modified saccharides,conjugates thereof and their manufacture Ceased GB0220198D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB0220198.6A GB0220198D0 (en) 2002-08-30 2002-08-30 Modified saccharides,conjugates thereof and their manufacture
NZ538703A NZ538703A (en) 2002-08-30 2003-09-01 Modified saccharides, having a linker moiety and a masked aldehyde group, to prevent and treat diseases caused by capsulate bacteria
ES03791149T ES2260682T3 (es) 2002-08-30 2003-09-01 Sacaridos modificados, sus conjugados y su produccion.
DK03791149T DK1534342T3 (da) 2002-08-30 2003-09-01 Modificerede saccharider, konjugater deraf og fremstilling deraf
MXPA05002315A MXPA05002315A (es) 2002-08-30 2003-09-01 Sacaridos modificados, conjugados del mismo y su produccion.
PCT/IB2003/004194 WO2004019992A1 (en) 2002-08-30 2003-09-01 Modified saccharides, conjugates thereof, and their manufacture
RU2005108992/04A RU2005108992A (ru) 2002-08-30 2003-09-01 Модифицированные сахариды, их конъюгаты и их изготовление
DE60303961T DE60303961T2 (de) 2002-08-30 2003-09-01 Modifizierte saccharide, deren konjugate sowie deren herstellung
JP2004532625A JP5268222B2 (ja) 2002-08-30 2003-09-01 改変された糖類、それらの結合体、およびそられの製造
CN2010101825535A CN101863998B (zh) 2002-08-30 2003-09-01 修饰糖、其缀合物及其制备方法
EP03791149A EP1534342B1 (en) 2002-08-30 2003-09-01 Modified saccharides, conjugates thereof, and their manufacture
AU2003260921A AU2003260921B2 (en) 2002-08-30 2003-09-01 Modified saccharides, conjugates thereof, and their manufacture
US10/526,124 US8895516B2 (en) 2002-08-30 2003-09-01 Modified saccharides, conjugates thereof, and their manufacture
AT03791149T ATE319481T1 (de) 2002-08-30 2003-09-01 Modifizierte saccharide, deren konjugate sowie deren herstellung
BR0314089-0A BR0314089A (pt) 2002-08-30 2003-09-01 Sacarìdeos modificados, conjugados do mesmo e sua fabricação
CN038237245A CN1688343B (zh) 2002-08-30 2003-09-01 修饰糖、其缀合物及其制备方法
CA2497167A CA2497167C (en) 2002-08-30 2003-09-01 Modified saccharides, conjugates thereof, and their manufacture
RU2008150551/13A RU2531909C2 (ru) 2002-08-30 2008-12-19 Модифицированные сахариды, их конъюгаты и их изготовление
JP2011228229A JP5314745B2 (ja) 2002-08-30 2011-10-17 改変された糖類、それらの結合体、およびそられの製造
US14/521,761 US20150166593A1 (en) 2002-08-30 2014-10-23 Modified saccharides, conjugates thereof, and their manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0220198.6A GB0220198D0 (en) 2002-08-30 2002-08-30 Modified saccharides,conjugates thereof and their manufacture

Publications (1)

Publication Number Publication Date
GB0220198D0 true GB0220198D0 (en) 2002-10-09

Family

ID=9943241

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0220198.6A Ceased GB0220198D0 (en) 2002-08-30 2002-08-30 Modified saccharides,conjugates thereof and their manufacture

Country Status (16)

Country Link
US (2) US8895516B2 (enExample)
EP (1) EP1534342B1 (enExample)
JP (2) JP5268222B2 (enExample)
CN (2) CN101863998B (enExample)
AT (1) ATE319481T1 (enExample)
AU (1) AU2003260921B2 (enExample)
BR (1) BR0314089A (enExample)
CA (1) CA2497167C (enExample)
DE (1) DE60303961T2 (enExample)
DK (1) DK1534342T3 (enExample)
ES (1) ES2260682T3 (enExample)
GB (1) GB0220198D0 (enExample)
MX (1) MXPA05002315A (enExample)
NZ (1) NZ538703A (enExample)
RU (2) RU2005108992A (enExample)
WO (1) WO2004019992A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
PT2191844E (pt) 2003-01-30 2014-06-04 Novartis Ag Vacinas injetáveis contra múltiplos serogrupos meningocócicos
WO2005051429A2 (en) * 2003-11-19 2005-06-09 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Targeted conjugates with a modified saccharide linker
EP1885734B1 (en) * 2005-05-06 2015-01-14 Novartis AG Immunogens for meningitidis-a vaccines
HUE032903T2 (hu) * 2005-12-22 2017-11-28 Glaxosmithkline Biologicals Sa Streptococcus pneumoniae kapszulárispoliszacharid-konjugátumok
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
AU2014200640B2 (en) * 2007-01-11 2016-06-16 Glaxosmithkline Biologicals Sa Modified saccharides
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
US9475864B2 (en) 2008-09-05 2016-10-25 University Of Massachusetts Methods, compositions and vaccines relating to Neisseria meningitidis antibodies
PL2445522T3 (pl) 2009-06-22 2018-01-31 Wyeth Llc Kompozycje immunogenne antygenów Staphylococcus aureus
SG177310A1 (en) 2009-06-22 2012-02-28 Wyeth Llc Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
SI2493498T1 (sl) * 2009-10-30 2017-07-31 Glaxosmithkline Biologicals Sa Čiščenje kapsularnih saharidov Staphylococcusa aureusa tipa 5 in tipa 8
SI2608805T2 (sl) 2010-08-23 2025-09-30 Wyeth Llc Stabilne formulacije antigenov rLP2086 neisserie meningitidis
BR112013005329A2 (pt) 2010-09-10 2017-05-02 Wyeth Llc variantes não lipidadas de antígenos orf2086 de neisseria meningitidis
MX2018011291A (es) 2012-03-09 2023-01-31 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
CN102861326A (zh) * 2012-09-19 2013-01-09 天津康希诺生物技术有限公司 流脑多糖-蛋白质缀合疫苗及制备方法
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
BR112016004463A2 (pt) 2013-09-08 2017-10-17 Pfizer composições de neisseria meningitidis e métodos das mesmas
US10668164B2 (en) * 2014-02-14 2020-06-02 Pfizer Inc. Immunogenic glycoprotein conjugates
WO2016132294A1 (en) 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2017158480A1 (en) * 2016-03-15 2017-09-21 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. Novel polysaccharide-protein conjugates and process to obtain thereof
AU2017321863B2 (en) 2016-09-02 2024-07-11 Sanofi Pasteur, Inc. Neisseria meningitidis vaccine
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
KR20240011879A (ko) 2017-02-24 2024-01-26 머크 샤프 앤드 돔 엘엘씨 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진
JP7218358B2 (ja) 2017-09-07 2023-02-06 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用
US11395849B2 (en) 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
WO2020182635A1 (en) * 2019-03-08 2020-09-17 Glaxosmithkline Biologicals Sa Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines
MX2022003682A (es) 2019-09-27 2022-04-25 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2427341A1 (fr) * 1978-06-02 1979-12-28 Delalande Sa Nouveaux derives aminoglycosidiques hemisynthetiques, leur procede de preparation et leur application en therapeutique
DE69104877T2 (de) * 1990-03-15 1995-03-16 Tanabe Seiyaku Co Polysulfat eines Cyclodextrinderivates und Verfahren zu dessen Herstellung.
WO1995018144A1 (en) * 1993-12-28 1995-07-06 Pfizer Inc. Steroidal glycosides
CA2189356A1 (en) * 1994-05-02 1995-11-09 Ting Chi Wong Process for preparation of glycosides of tumor-associated carbohydrate antigens
DK0959905T3 (da) * 1997-01-21 2010-04-06 Sanofi Pasteur Polysaccharid-peptid-konjugater
CA2266718C (en) * 1997-08-08 2007-05-22 Behringwerke Aktiengesellschaft Polysaccharide conjugates of biomolecules
US5929049A (en) * 1997-08-08 1999-07-27 Dade Behring Marburg Gmbh Polysaccharide conjugates of biomolecules
US5952454A (en) * 1997-12-12 1999-09-14 The United States Of America As Represented By The Department Of Health And Human Services Linking compounds useful for coupling carbohydrates to amine-containing carriers
BR0308768A (pt) 2002-03-26 2005-02-15 Chiron Srl Sacarìdeos modificados possuindo estabilidade melhorada em água
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture

Also Published As

Publication number Publication date
ES2260682T3 (es) 2006-11-01
CA2497167C (en) 2011-07-12
NZ538703A (en) 2006-09-29
RU2531909C2 (ru) 2014-10-27
RU2005108992A (ru) 2005-11-10
US20060263390A1 (en) 2006-11-23
JP2012017342A (ja) 2012-01-26
BR0314089A (pt) 2005-11-16
ATE319481T1 (de) 2006-03-15
MXPA05002315A (es) 2005-06-08
JP5268222B2 (ja) 2013-08-21
JP2006511465A (ja) 2006-04-06
JP5314745B2 (ja) 2013-10-16
CN1688343A (zh) 2005-10-26
DE60303961D1 (de) 2006-05-04
EP1534342A1 (en) 2005-06-01
DK1534342T3 (da) 2006-07-10
RU2008150551A (ru) 2010-06-27
CN101863998B (zh) 2012-08-29
US20150166593A1 (en) 2015-06-18
CN1688343B (zh) 2010-09-08
WO2004019992A1 (en) 2004-03-11
CA2497167A1 (en) 2004-03-11
AU2003260921B2 (en) 2008-03-06
AU2003260921A1 (en) 2004-03-19
EP1534342B1 (en) 2006-03-08
US8895516B2 (en) 2014-11-25
CN101863998A (zh) 2010-10-20
DE60303961T2 (de) 2006-10-26

Similar Documents

Publication Publication Date Title
GB0220198D0 (en) Modified saccharides,conjugates thereof and their manufacture
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
RU2412944C2 (ru) Иммуногены для вакцин против менингита а
JP2005532287A5 (enExample)
WO2005030258A3 (en) Small molecule compositions and methods for increasing drug efficiency using compositions thereof
MXPA03002779A (es) Derivados de glucopiranosiloxibencilbenceno y composiciones medicinales conteniendo los mismos.
CA2413190A1 (en) Methods for treating rheumatic diseases using a soluble ctla4 molecule
WO2008106186A3 (en) Activated polyoxazolines and compositions comprising the same
WO2002062810A3 (en) Linkable sialyl lewis x analogs
NZ541974A (en) Nucleotide phosphoramidates as anticancer agents
WO2001081365A3 (en) Metal chelating compositions
DK1327146T3 (da) Forbindelse med et forgrenet linkermolekyle
WO2011010084A3 (en) Cyclosporin conjugates
DE60128296D1 (de) Saccharid-Alkylenoxyderivate und Tinte
CA2423007A1 (en) Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
DE60114640D1 (en) Antithrombosemittel
GB0501964D0 (en) Chemical compounds
WO2006032893A3 (en) Trityl derivatives for enhancing mass spectrometry
WO2001066155A3 (en) Actinium-225 complexes and conjugates for radioimmunotherapy
WO2008065181A3 (en) Pyran derivatives, process of preparation and use thereof in perfumery and flavouring
EP1907419A4 (en) PREPARATION OF INSULIN CONJUGATES
WO2006012490A3 (en) Ketogenic saccharides
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
WO2010079499A3 (en) Novel hydrazide containing taxane conjugates
DK1250335T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)